CoChat

Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice

Open access
Arts, Josje H.E., Irfan, Muhammad-Adeel, Keene, Athena M., Kreiling, Reinhard, Lyon, Delina, Maier, Monika, Michel, Karin, Neubauer, Nicole, Petry, Thomas, Sauer, Ursula G., Warheit, David, Wiench, Karin, Wohlleben, Wendel, Landsiedel, Robert · 2016 · Regulatory Toxicology and Pharmacology
Cited by 128

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Case studies covering carbonaceous nanomaterials, metal oxide and metal sulphate nanomaterials, amorphous silica and organic pigments were performed to assess the Decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). The usefulness of the DF4nanoGrouping for nanomaterial hazard assessment was confirmed. In two tiers that rely exclusively on non-animal test methods followed by a third tier, if necessary, in which data from rat short-term inhalation studies are evaluated, nanomaterials are assigned to one of four main groups (MGs). The DF4nanoGrouping proved efficient in sorting out nanomaterials that could undergo hazard assessment without further testing. These are soluble nanomaterials (MG1) whose further hazard assessment should rely on read-across to the dissolved materials, high aspect-ratio nanomaterials (MG2) which could be assessed according to their potential fibre toxicity and passive nanomaterials (MG3) that only elicit effects under pulmonary overload conditions. Thereby, the DF4nanoGrouping allows identifying active nanomaterials (MG4) that merit in-depth investigations, and it provides a solid rationale for their sub-grouping to specify the further information needs. Finally, the evaluated case study materials may be used as source nanomaterials in future read-across applications. Overall, the DF4nanoGrouping is a hazard assessment strategy that strictly uses animals as a last resort.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.yrtph.2015.11.020

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 128

Metadata

Authors
Arts, J. H. E., Irfan, M.-A., Keene, A. M., Kreiling, R., Lyon, D., Maier, M., Michel, K., Neubauer, N., Petry, T., Sauer, U. G., Warheit, D., Wiench, K., Wohlleben, W., & Landsiedel, R.
Venue
Regulatory Toxicology and Pharmacology
Publisher
Elsevier BV
Published
2016-04
Volume
76
Pages
234-261
ISSN
0273-2300 (ISSN-L)
OpenAlex
W2195616206
Cited by
128
References
7
FWCI
6.00
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice. https://app.cochat.ai/papers/10.1016/j.yrtph.2015.11.020
The paper
Arts, J. H. E., Irfan, M.-A., Keene, A. M., Kreiling, R., Lyon, D., Maier, M., Michel, K., Neubauer, N., Petry, T., Sauer, U. G., Warheit, D., Wiench, K., Wohlleben, W., & Landsiedel, R. (2016). Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice. Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2015.11.020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.